Table 4.
Odds ratio | 95% confidence interval (β) | P value | |
Antibodies against oxidized low-density lipoprotein in the lag phase | 0.431 | 0.023–7.945 | Not significant |
Antibodies against oxidized low-density lipoprotein in the propagation phase | 0.155 | 0.010–2.295 | Not significant |
Antibodies against oxidized low-density lipoprotein in the decomposition phase | 0.047 | 0.008–0.282 | 0.001 |
Plasma lipoprotein phospholipase A2 activity | 1.044 | 1.013–1.077 | 0.006 |
The model includes antibodies against oxidized low-density lipoprotein in the lag phase, the propagation phase and the decomposition phase, and plasma lipoprotein phospholipase A2 activity as defined from univariate analysis after adjustment for age and female gender.